Lv41
676 积分 2021-11-06 加入
Tektin4 loss promotes triple-negative breast cancer metastasis through HDAC6-mediated tubulin deacetylation and increases sensitivity to HDAC6 inhibitor
1小时前
待确认
Pathologic complete response (pCR) rates for patients with HR+/HER2− high-risk, early-stage breast cancer (EBC) by clinical and molecular features in the phase II I-SPY2 clinical trial
1天前
待确认
Fasting improves therapeutic response in hepatocellular carcinoma through p53-dependent metabolic synergism
10天前
已完结
Palbociclib plus letrozole versus weekly paclitaxel, both in combination with trastuzumab plus pertuzumab, as neoadjuvant treatment for patients with HR-positive/HER2-positive early breast cancer: primary results from the randomized phase II TOUCH trial (IBCSG 55-17)
1个月前
已完结
Paradigms on Immunotherapy Combinations with Chemotherapy
3个月前
已完结
Parietal lobe epilepsy: the great imitator among focal epilepsies
5个月前
已完结
Luminal B Breast Cancer: Molecular Characterization, Clinical Management, and Future Perspectives
5个月前
已完结
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities
5个月前
已完结
SYTL4 downregulates microtubule stability and confers paclitaxel resistance in triple-negative breast cancer
5个月前
已完结
Superenhancer drives a tumor-specific splicing variant of MARCO to promote triple-negative breast cancer progression
5个月前
已完结
皖公网安备34019202002308
